| Status: Excluded due to NICE appraisal | |
Product meets AWMSG exclusion criteria due to NICE appraisal TA953: Fluocinolone acetonide intravitreal implant for treating chronic diabetic macular oedema |
|
Medicine details |
|
| Medicine name | fluocinolone acetonide (Iluvien®) |
| Formulation | 190 micrograms intravitreal implant |
| Reference number | 519 |
| Indication | Treatment of diabetic macular oedema |
| Company | Alimera Sciences Limited |
| BNF chapter | Endocrine system |
| Assessment type | N/A |
| Status | Excluded due to NICE appraisal |
| Date of issue | 29/06/2012 |
| NICE guidance | TA953: Fluocinolone acetonide intravitreal implant for treating chronic diabetic macular oedema |